Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-040034
Filing Date
2019-08-14
Accepted
2019-08-14 16:02:06
Documents
49
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv527004_10q.htm 10-Q 489708
2 EXHIBIT 31.1 tv527004_ex31-1.htm EX-31.1 10019
3 EXHIBIT 32.1 tv527004_ex32-1.htm EX-32.1 5282
  Complete submission text file 0001144204-19-040034.txt   3485351

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgrx-20190630.xml EX-101.INS 813273
5 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20190630.xsd EX-101.SCH 35795
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20190630_cal.xml EX-101.CAL 33744
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20190630_def.xml EX-101.DEF 79282
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20190630_lab.xml EX-101.LAB 253492
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20190630_pre.xml EX-101.PRE 212322
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 191026104
SIC: 2834 Pharmaceutical Preparations